H Eggemann
Overview
Explore the profile of H Eggemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
248
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schreiber J, Ignatov A, Burger E, Meinecke A, Eggemann H
J Cancer Res Clin Oncol
. 2022 Dec;
149(9):5665-5676.
PMID: 36538146
Purpose: In recent years, therapeutic strategies based on tumour biology have increased significantly. We aimed to provide an overview of the recent changes in patient characteristics, treatment procedures and survival...
2.
Lukassek J, Ignatov A, Faerber J, Costa S, Eggemann H
Arch Gynecol Obstet
. 2019 Oct;
300(6):1637-1644.
PMID: 31631250
Purpose: Although puerperal mastitis is a common disease, published data are poor. Increasing rates of community-acquired MRSA (CA-MRSA) cases are reported in the USA. However, information about common pathogens and...
3.
Eggemann H, Ignatov A, Frauchiger-Heuer H, Amse T, Costa S
Arch Gynecol Obstet
. 2018 Jan;
297(2):479-485.
PMID: 29302807
Objective: To compare the impact of peritoneal closure on postoperative pain after vaginal (VH) and laparoscopic-assisted vaginal hysterectomy (LAVH). Study Design: A prospective, randomized, double-blind study was designed to investigate...
4.
Grumpelt A, Ignatov A, Tchaikovski S, Burger E, Costa S, Eggemann H
J Cancer Res Clin Oncol
. 2016 Jan;
142(5):1109-16.
PMID: 26809246
Introduction: Elderly breast cancer patients aged ≥75 years are underrepresented in most studies. Therefore, data on cancer characteristics, adjuvant treatment and survival in elderly patients are missing. Patients And Methods:...
5.
Eggemann H, Ehricke J, Ignatov T, Fettke F, Semczuk A, Costa S, et al.
Cancer Invest
. 2015 Apr;
33(5):193-6.
PMID: 25831456
Elevated platelet count occasionally is associated with gynecologic malignancies. We investigated the level of platelet count in 450 patients with gynecologic tumors. Ovarian cancer patients have increased platelet count associated...
6.
Loibl S, Untch M, Fasching P, Eggemann H, Jackisch C, Blohmer J, et al.
Ann Oncol
. 2014 Sep;
25(12):2363-2372.
PMID: 25223482
Background: The GeparQuinto study showed that adding bevacizumab to 24 weeks of anthracycline-taxane-based neoadjuvant chemotherapy increases pathological complete response (pCR) rates overall and specifically in patients with triple-negative breast cancer...
7.
Ignatov T, Eggemann H, Costa S, Roessner A, Kalinski T, Ignatov A
J Cancer Res Clin Oncol
. 2014 May;
140(9):1457-63.
PMID: 24825122
Background: The aim of the current study was to investigate the role of BRCA1 promoter methylation as predictive factor of response to platinum-taxane-based therapy in sporadic ovarian cancer. Patients And...
8.
Eggemann H, Ignatov T, Beni A, Costa S, Ortmann O, Ignatov A
Geburtshilfe Frauenheilkd
. 2014 Apr;
73(10):1028-1034.
PMID: 24771892
The aim of this study was to investigate the value of intraoperative ultrasound in breast-conserving operations and to compare it with standard procedures. For this purpose 307 women with palpable...
9.
Gerber B, Loibl S, Eidtmann H, Rezai M, Fasching P, Tesch H, et al.
Ann Oncol
. 2013 Oct;
24(12):2978-84.
PMID: 24136883
Background: We evaluated the pathological complete response (pCR) rate after neoadjuvant epirubicin, (E) cyclophosphamide (C) and docetaxel containing chemotherapy with and without the addition of bevacizumab in patients with triple-negative...
10.
Eiermann W, Rezai M, Kummel S, Kuhn T, Warm M, Friedrichs K, et al.
Ann Oncol
. 2012 Nov;
24(3):618-24.
PMID: 23136233
Background: We carried out a prospective clinical study to evaluate the impact of the Recurrence Score (RS) on treatment decisions in early breast cancer (EBC). Patients And Methods: A total...